跳至主要内容
临床试验/ACTRN12608000077369
ACTRN12608000077369已完成不适用

Double-blind randomised clinical trial comparison of partial coherence interferometry and ultrasound biometry for the determination of intraocular lens power measured by the postoperative refractive outcome

Ian Favilla0 个研究点目标入组 205 人开始时间: 2008年2月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
205

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
o limit 至 o limit(—)
性别
All

入选标准

  • Patients referred for consideration of age-related cataract surgery, approved for surgery and consented to surgery

排除标准

  • 未提供

研究者

发起方
Ian Favilla

相似试验

撤回
4 期
How long rocuronium lasts when given subcutaneously to adult surgical patientsInadvertent subcutaneous injection of rocuroniumAnaesthesiology - Anaesthetics
ACTRN12614001215617Fremantle Hospital20
已完成
不适用
A double-blind randomised controlled trial comparing porcine dermal collagen patch saphenoplasty with conventional saphenofermoral ligation to prevent recurrent saphenofemoral incompetenceTopic: Generic Health Relevance and Cross Cutting ThemesSubtopic: Generic Health Relevance (all Subtopics)Disease: SurgerySurgeryVaricose vein
ISRCTN43505974orthern Lincolnshire and Goole Hospitals NHS Foundation Trust (UK)100
已完成
不适用
A double blind randomised controlled trial comparing porcine dermal collagen patch saphenoplasty with conventional saphenofemoral ligation to prevent recurrent saphenofemoral incompetence
ISRCTN17706253Record Provided by the NHSTCT Register - 2007 Update - Department of Health80
已完成
3 期
A double-blind randomized controlled trial comparing 0.75mg of Palonosetron with 1mg of Granisetron for the control of highly emetogenic chemotherapy-induced emesis.Malignant tumor (lung cancer,gastric cancer,esophagus cancer,cervical cancer,endometrial cancer,head and neck cancer,etc)
JPRN-UMIN000004863Pharma Valley Center,Shizuoka Organization for Creation Industries840
已完成
3 期
A double-blind randomized controlled trial comparing 3mg and 1mg of ranisetron for the control of chemotherapy-induced acute emesisMalignant tumor (breast cancer, lung cancer, gastric cancer, esophagus cancer, colorectal cancer, etc)
JPRN-UMIN000000984Pharma Valley Center, Shizuoka Organization for Creation Industries360